Skip to main content

ORBIMED ADVISORS LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1055951 New York, NY

Position in AXSM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$28,779,567
-$7,377,360 QoQ
Shares Held
117,578
-45.0% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#68
of 500 holders
Holding Since
Mar 2021
7 quarters on record
Voting authority Sole 17% Shared 0% None 83%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Derivatives in AXSM

reported options exposure · as of Mar 31, 2021
CallValue
$0
CallShares
0
PutValue
$2,831,000
PutShares
50,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. AXSM ranks #34 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AXSM

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,779,567 117,578
2026-03-31 $36,156,927 213,921
2025-12-31 $46,230,019 253,121
2025-09-30 $64,587,110 531,800
2025-06-30 $44,668,481 427,900
2025-03-31 $45,100,821 386,700
2021-03-31 $2,831,000 50,000